BioOne.org will be down briefly for maintenance on 13 August 2025 between 18:00-21:00 Pacific Time US. We apologize for any inconvenience.
Registered users receive a variety of benefits including the ability to customize email alerts, create favorite journals list, and save searches.
Please note that a BioOne web account does not automatically grant access to full-text content. An institutional or society member subscription is required to view non-Open Access content.
Contact helpdesk@bioone.org with any questions.
Polyglutamine diseases are a group of neurodegenerative disorders characterized by the expansion of a CAG trinucleotide in a protein-coding gene. The translation of these expanded repeats leads to long polyglutamine tracts that increase the potential of the protein to aggregate itself and other proteins into the pathological amyloid conformation. Machado-Joseph disease (MJD), also known as Spinocerebellar Ataxia 3, is the second most common polyglutamine disease behind Huntington disease. In MJD, the CAG expansion occurs in the ATXN3 gene. Currently there are no FDA-approved therapies to prevent or cure MJD. However, RNA-based therapies that silence the expression of or alter the structure of the mutant protein have the potential to prevent and ameliorate the disease. Here, we will review how RNA interference (RNAi) and antisense oligonucleotides (AONs) could potentially be used to target ATXN3. These technologies could mediate allele-specific silencing of mutant ATXN3 alleles but also allele non-specific silencing for individuals without a targetable polymorphism. Both RNAi and AONs could be used to promote mRNA degradation and translational inhibition; in addition AONs may be used as splicing modulators. The evidence suggests that viral-mediated delivery of RNAi therapies may have longer term potency than liposomal-mediated delivery of RNAi or AON therapies; however, this has not been fully explored in animal models. Nevertheless, there are promising results from studies of MJD and similar neurodegenerative disorders that suggest that RNAi and AON technology may be a viable long-term treatment therapy.
Male and female reproductive success of plants is controlled by biotic, abiotic, and genetic factors which often involve resource allocations between plant organs. The purpose of this study was to examine resource tradeoffs in fly poison, Amianthium muscaetoxicum, and whether tradeoffs affect plant fitness. At Mountain Lake Biological Station, Virginia, bulb and leaf number were counted, and data from individual anthers and flowers were analyzed, from 23 A. muscaetoxicum plants. No negative correlations were observed between growth and reproduction, suggesting that no resource tradeoffs were occurring. A significant positive relationship was observed between flower number and percent seed set, indicating that a larger floral display may attract more pollinators and increase female fitness.
This article is only available to subscribers. It is not available for individual sale.
Access to the requested content is limited to institutions that have
purchased or subscribe to this BioOne eBook Collection. You are receiving
this notice because your organization may not have this eBook access.*
*Shibboleth/Open Athens users-please
sign in
to access your institution's subscriptions.
Additional information about institution subscriptions can be foundhere